Literature DB >> 16250781

Reliability and validity of dyspnea measures in patients with obstructive lung disease.

E G Eakin1, D E Sassi-Dambron, A L Ries, R M Kaplan.   

Abstract

Dyspnea, the clinical term for shortness of breath, is the primary symptom and an important outcome measure in evaluations of patients with lung disease. It is a subjective symptom that has proved difficult to quantify. Many dyspnea measures are available, yet it is difficult, based on the existing literature, to determine the most reliable and valid. In this study, we evaluated 6 measures of dyspnea for reliability and validity: (a) Baseline Dyspnea Index (BDI) and Transition Dyspnea Index, (b) UCSD Shortness of Breath Questionnaire (SOBQ),(c) American Thoracic Society Dyspnea Scale, (d) Oxygen Cost Diagram, (e) Visual Analog Scale, and (f) Borg Scale. Subjects were 143 patients (74 women) and 69 men) with obstructive lung disease, ages 40 to 86, FEV(1.0) 0.36 to 3.53 L, FVC 1.07 to 5.74 L. Dyspnea measures were assessed for test-retest reliability internal consistency, interrater reliability, and construct validity (i.e., correlations among dyspnea measures and correlations of dyspnea measures with exercise tolerance, health-related quality of life, lung function, anxiety, and depression). Results suggest that the SOBQ and BDI demonstrated the highest levels of reliability and validity among the dyspnea measures examined.

Entities:  

Year:  1995        PMID: 16250781     DOI: 10.1207/s15327558ijbm0202_3

Source DB:  PubMed          Journal:  Int J Behav Med        ISSN: 1070-5503


  28 in total

1.  CHRONIC OBSTRUCTIVE LUNG DISEASE. II. RELATIONSHIP OF CLINICAL AND PHYSIOLOGIC FINDINGS TO THE SEVERITY OF AIRWAYS OBSTRUCTION.

Authors:  B BURROWS; A H NIDEN; W R BARCLAY; J E KASIK
Journal:  Am Rev Respir Dis       Date:  1965-05

2.  The clinical diagnosis of pulmonary emphysema; an experimental study.

Authors:  C M FLETCHER
Journal:  Proc R Soc Med       Date:  1952-09

3.  Psychologic and physiologic factors related to dyspnea in subjects with chronic obstructive pulmonary disease.

Authors:  A G Gift; S M Plaut; A Jacox
Journal:  Heart Lung       Date:  1986-11       Impact factor: 2.210

4.  Perceived exertion as an indicator of somatic stress.

Authors:  G Borg
Journal:  Scand J Rehabil Med       Date:  1970

5.  A measure of quality of life for clinical trials in chronic lung disease.

Authors:  G H Guyatt; L B Berman; M Townsend; S O Pugsley; L W Chambers
Journal:  Thorax       Date:  1987-10       Impact factor: 9.139

6.  Validity of a quality of well-being scale as an outcome measure in chronic obstructive pulmonary disease.

Authors:  R M Kaplan; C J Atkins; R Timms
Journal:  J Chronic Dis       Date:  1984

7.  Psychophysical bases of perceived exertion.

Authors:  G A Borg
Journal:  Med Sci Sports Exerc       Date:  1982       Impact factor: 5.411

8.  How should we measure function in patients with chronic heart and lung disease?

Authors:  G H Guyatt; P J Thompson; L B Berman; M J Sullivan; M Townsend; N L Jones; S O Pugsley
Journal:  J Chronic Dis       Date:  1985

9.  Dyspnoea, disability, and distance walked: comparison of estimates of exercise performance in respiratory disease.

Authors:  C R McGavin; M Artvinli; H Naoe; G J McHardy
Journal:  Br Med J       Date:  1978-07-22

10.  Variability of breathlessness measurement in patients with chronic obstructive pulmonary disease.

Authors:  M J Belman; L R Brooks; D J Ross; Z Mohsenifar
Journal:  Chest       Date:  1991-03       Impact factor: 9.410

View more
  17 in total

1.  Patients' self-reports of dyspnea: An important and independent outcome in chronic obstructive pulmonary disease.

Authors:  E G Eakin; R M Kaplan; A L Ries; D E Sassi-Dambron
Journal:  Ann Behav Med       Date:  1996-06

2.  Impact of symptom burden in post-surgical non-small cell lung cancer survivors.

Authors:  Amy E Lowery; Paul Krebs; Elliot J Coups; Marc B Feinstein; Jack E Burkhalter; Bernard J Park; Jamie S Ostroff
Journal:  Support Care Cancer       Date:  2013-09-10       Impact factor: 3.603

3.  Current dyspnea among long-term survivors of early-stage non-small cell lung cancer.

Authors:  Marc B Feinstein; Paul Krebs; Elliot J Coups; Bernard J Park; Richard M Steingart; Jack Burkhalter; Amy Logue; Jamie S Ostroff
Journal:  J Thorac Oncol       Date:  2010-08       Impact factor: 15.609

4.  The effects of a telehealth coping skills intervention on outcomes in chronic obstructive pulmonary disease: primary results from the INSPIRE-II study.

Authors:  James A Blumenthal; Charles F Emery; Patrick J Smith; Francis J Keefe; Karen Welty-Wolf; Stephanie Mabe; Tereza Martinu; Julie J Johnson; Michael A Babyak; Virginia F O'Hayer; Philip T Diaz; Michael Durheim; Donald Baucom; Scott M Palmer
Journal:  Psychosom Med       Date:  2014-10       Impact factor: 4.312

5.  Efficacy of Indacaterol/Glycopyrronium in Patients with COPD Who Have Increased Dyspnea with Daily Activities.

Authors:  Donald A Mahler; Dorothy L Keininger; Karen Mezzi; Robert Fogel; Donal Banerji
Journal:  Chronic Obstr Pulm Dis       Date:  2016-09-09

6.  Development and validation of the living with chronic obstructive pulmonary disease questionnaire.

Authors:  Stephen P McKenna; David M Meads; Lynda C Doward; James Twiss; Robin Pokrzywinski; Dennis Revicki; Cameron J Hunter; G Alastair Glendenning
Journal:  Qual Life Res       Date:  2011-02-11       Impact factor: 4.147

7.  Fatigue and functional impairment in early-stage non-small cell lung cancer survivors.

Authors:  Robert Hung; Paul Krebs; Elliot J Coups; Marc B Feinstein; Bernard J Park; Jack Burkhalter; Jamie S Ostroff
Journal:  J Pain Symptom Manage       Date:  2011-01-08       Impact factor: 3.612

Review 8.  Clinically important changes in health-related quality of life for patients with chronic obstructive pulmonary disease: an expert consensus panel report.

Authors:  Kathleen W Wyrwich; Stephan D Fihn; William M Tierney; Kurt Kroenke; Ajit N Babu; Fredric D Wolinsky
Journal:  J Gen Intern Med       Date:  2003-03       Impact factor: 5.128

9.  Patient-reported dyspnea in COPD reliability and association with stage of disease.

Authors:  Donald A Mahler; Joseph Ward; Laurie A Waterman; Corliss McCusker; Richard ZuWallack; John C Baird
Journal:  Chest       Date:  2009-08-20       Impact factor: 9.410

10.  Evaluation of three scales of dyspnea in chronic obstructive pulmonary disease.

Authors:  S K Chhabra; A K Gupta; M Z Khuma
Journal:  Ann Thorac Med       Date:  2009-07       Impact factor: 2.219

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.